Discontinued — last reported Q1 '22

Total Equity Investments

Non-Current Assets

Amgen Total Equity Investments increased by 39.2% to $6.82B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 34.8%, from $5.06B to $6.82B.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2021
Last reportedQ1 2022

How to read this metric

Growth in this metric indicates strategic expansion through partnerships or minority equity positions.

Detailed definition

This represents the total carrying value of the company's investments in the equity securities of other entities, such a...

Peer comparison

Common in energy and industrial sectors where joint ventures are prevalent; peers report these as non-current assets.

Metric ID: total_equity_investments

Historical Data

8 periods
 Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$4.51B$3.99B$3.47B$5.06B$4.19B$5.48B$4.90B$6.82B
QoQ Change-11.7%-12.9%+45.7%-17.2%+30.9%-10.7%+39.2%
YoY Change-7.2%+37.6%+41.2%+34.8%
Range$3.47B$6.82B
CAGR+26.6%
Avg YoY Growth+26.6%
Median YoY Growth+36.2%

Frequently Asked Questions

What is Amgen's total equity investments?
Amgen (AMGN) reported total equity investments of $6.82B in Q3 2025.
How has Amgen's total equity investments changed year-over-year?
Amgen's total equity investments increased by 34.8% year-over-year, from $5.06B to $6.82B.
What does total equity investments mean?
The total value of the company's ownership stakes in other businesses.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.